Cytoxan



Indications and Reactions:

Role Indications Reactions
Primary
Breast Cancer 34.7%
Multiple Myeloma 6.1%
Non-hodgkin's Lymphoma 5.3%
Chronic Lymphocytic Leukaemia 5.2%
Premedication 4.6%
Product Used For Unknown Indication 4.3%
Pain 3.9%
Hypertension 3.7%
B-cell Lymphoma 3.6%
Diffuse Large B-cell Lymphoma 3.6%
Prophylaxis 3.6%
Lymphoma 3.4%
Plasma Cell Myeloma 2.8%
Breast Cancer Metastatic 2.7%
Chemotherapy 2.4%
Nausea 2.4%
Multiple Sclerosis 2.2%
Prostate Cancer 2.2%
Drug Use For Unknown Indication 1.8%
Insomnia 1.8%
Vomiting 13.9%
Febrile Neutropenia 9.4%
Dehydration 6.7%
Pyrexia 6.7%
Neutropenia 6.1%
Thrombocytopenia 6.1%
Pancytopenia 5.6%
Pneumonia 5.0%
White Blood Cell Count Decreased 5.0%
Sepsis 4.4%
Dyspnoea 3.9%
Hypersensitivity 3.9%
Palmar-plantar Erythrodysaesthesia Syndrome 3.9%
Death 3.3%
Alopecia 2.8%
Infection 2.8%
Malignant Neoplasm Progression 2.8%
Nausea 2.8%
Renal Failure Acute 2.8%
Cellulitis 2.2%
Secondary
Breast Cancer 22.4%
Drug Use For Unknown Indication 13.6%
Product Used For Unknown Indication 12.9%
Behcet's Syndrome 12.5%
Chronic Lymphocytic Leukaemia 7.6%
Multiple Myeloma 5.6%
Acute Lymphocytic Leukaemia 3.0%
Diffuse Large B-cell Lymphoma 2.9%
Non-hodgkin's Lymphoma 2.6%
B-cell Lymphoma 2.2%
Pain 1.9%
Breast Cancer Metastatic 1.7%
Hodgkin's Disease 1.7%
Plasma Cell Myeloma 1.4%
Multiple Sclerosis 1.4%
Premedication 1.4%
Chemotherapy 1.4%
Vasculitis 1.3%
Hypertension 1.3%
Amyloidosis 1.2%
Vomiting 11.3%
Febrile Neutropenia 9.4%
Pyrexia 9.4%
Squamous Cell Carcinoma Of Skin 8.2%
Sepsis 7.2%
Skin Cancer 6.3%
Thrombocytopenia 5.6%
White Blood Cell Count Decreased 4.7%
Tachycardia 4.1%
Respiratory Failure 3.8%
Pneumonitis 3.4%
Nausea 3.1%
Pleural Effusion 3.1%
Progressive Multifocal Leukoencephalopathy 3.1%
Squamous Cell Carcinoma 3.1%
Dyspnoea 2.8%
Hypoaesthesia 2.8%
Neutropenia 2.8%
Palmar-plantar Erythrodysaesthesia Syndrome 2.8%
Pneumonia 2.8%
Concomitant
Breast Cancer 14.4%
Drug Use For Unknown Indication 13.2%
Product Used For Unknown Indication 12.7%
Multiple Myeloma 11.4%
Metastases To Bone 7.3%
Chemotherapy 6.9%
Pain 5.4%
Breast Cancer Metastatic 4.5%
Depression 3.2%
Multiple Sclerosis 2.8%
Nuclear Magnetic Resonance Imaging 2.7%
Osteoporosis 2.5%
Prophylaxis 1.9%
Nausea 1.8%
Hypertension 1.7%
Chronic Lymphocytic Leukaemia 1.6%
Anxiety 1.6%
Premedication 1.5%
Non-hodgkin's Lymphoma 1.5%
Systemic Lupus Erythematosus 1.5%
Weight Decreased 15.7%
Weight Increased 8.0%
Wound Drainage 7.7%
Vomiting 7.3%
Tooth Extraction 6.4%
Pyrexia 5.2%
Wheezing 5.0%
White Blood Cell Count Decreased 5.0%
Death 4.9%
White Blood Cell Count Increased 3.6%
Wound Infection Staphylococcal 3.6%
Thrombocytopenia 3.5%
Urticaria 3.2%
Drug Ineffective 3.1%
Neutropenia 3.1%
Vision Blurred 3.1%
Wound Secretion 3.1%
Febrile Neutropenia 3.0%
Rash 2.7%
Sepsis 2.7%
Interacting
Prophylaxis Of Nausea And Vomiting 100.0%
Infusion Site Phlebitis 50.0%
Middle Insomnia 50.0%